Biotage AB Financials
| BIOT Stock | SEK 152.30 0.50 0.33% |
Biotage |
Understanding current and past Biotage AB Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Biotage AB's financial statements are interrelated, with each one affecting the others. For example, an increase in Biotage AB's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Biotage AB's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Biotage AB. Check Biotage AB's Beneish M Score to see the likelihood of Biotage AB's management manipulating its earnings.
Biotage AB Stock Summary
Biotage AB competes with Cantargia, BioArctic, Hansa Biopharma, and BioInvent International. Biotage AB , a life science company, provides solutions, knowledge, and experience in the areas of organic and analytical chemistry, as well as for industrial applications in the United States, Europe, Japan, China, and internationally. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, and academic institutions and commercial, hospitalbio-analytical, and forensic laboratories, as well as laboratories within food and environmental analysis. Biotage AB operates under Medical Instruments Supplies classification in Sweden and is traded on Stockholm Stock Exchange. It employs 438 people.| Foreign Associate | USA |
| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0000454746 |
| Business Address | Box 8, Uppsala, |
| Sector | Life Sciences Tools & Services |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.biotage.com |
| Phone | 46 18 56 59 00 |
| Currency | SEK - Swedish Kronor |
You should never invest in Biotage AB without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Biotage Stock, because this is throwing your money away. Analyzing the key information contained in Biotage AB's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Biotage AB Key Financial Ratios
Biotage AB's financial ratios allow both analysts and investors to convert raw data from Biotage AB's financial statements into concise, actionable information that can be used to evaluate the performance of Biotage AB over time and compare it to other companies across industries.| Return On Equity | 0.18 | |||
| Return On Asset | 0.11 | |||
| Target Price | 229.33 | |||
| Number Of Employees | 510 | |||
| Beta | 0.81 |
Biotage Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biotage AB's current stock value. Our valuation model uses many indicators to compare Biotage AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biotage AB competition to find correlations between indicators driving Biotage AB's intrinsic value. More Info.Biotage AB is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.61 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Biotage AB is roughly 1.64 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biotage AB's earnings, one of the primary drivers of an investment's value.Biotage AB Systematic Risk
Biotage AB's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Biotage AB volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Biotage AB correlated with the market. If Beta is less than 0 Biotage AB generally moves in the opposite direction as compared to the market. If Biotage AB Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Biotage AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Biotage AB is generally in the same direction as the market. If Beta > 1 Biotage AB moves generally in the same direction as, but more than the movement of the benchmark.
Biotage AB December 1, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Biotage AB help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Biotage AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Biotage AB based on widely used predictive technical indicators. In general, we focus on analyzing Biotage Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Biotage AB's daily price indicators and compare them against related drivers.
| Information Ratio | (0.25) | |||
| Maximum Drawdown | 9.07 | |||
| Value At Risk | (4.27) | |||
| Potential Upside | 2.78 |
Additional Tools for Biotage Stock Analysis
When running Biotage AB's price analysis, check to measure Biotage AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotage AB is operating at the current time. Most of Biotage AB's value examination focuses on studying past and present price action to predict the probability of Biotage AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotage AB's price. Additionally, you may evaluate how the addition of Biotage AB to your portfolios can decrease your overall portfolio volatility.